A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction

Completed

• Conditions: SBO - Small Bowel Obstruction

• Registration Number: NCT06223620
• Lead Sponsor: Methodist Health System

Brief Summary

The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.

Detailed Description

Performance of contrast study has been a part of the protocols at multiple institutions of the southwestern surgical congress. Plan to perform a retrospective review of management protocols at these institutions. Wish to know whether the implementation of a standardized, protocol-driven pattern of practice involving the performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.

The objective of the study is to review performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.

Performance of contrast study has been a part of the protocols at multiple institutions of the southwestern surgical congress.

Hypothesize that implementation of a standardized, protocol-driven pattern of practice involving the performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.

Study Timeline

• Study Start: 2018-07-30
• Primary Completion: 2019-12-31
• Study Completion: 2019-12-31
• Study First Submitted: 2023-10-18
• Status Verified: 2024-01
• Study First Submitted QC: 2024-01-16
• Last Update Submitted: 2024-01-16
• Study First Posted: 2024-01-25
• Last Update Posted: 2024-01-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 504

Inclusion Criteria

• • Adults aged 18-89 years of age

  • Patients presenting with SBO

Exclusion Criteria

• • Prisoners

  • Pregnant women

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Morbidity and length of stay	1 year	Morbidity and length of stay

Secondary Outcome Measures

Name	Time	Method
Aspirin(ASA )class	1 year	number of aspirin class
time of contrast given	1 year	rate of Contrast given
admit date	1 year	Number of patients admitting to the hospital
comorbidities	1 year	number of comorbidities associated
Patient demographics	1 year	number of patients (age, sex, weight, height)
labs	1 year	number of labs done
discharge date	1 year	number of patients discharging
admission service	1 year	Number of services related to admissions
surgical history	1 year	number of surgeries in the past

Trial Locations

Locations (1)

Methodist Dallas Medical Center; 🇺🇸 Dallas, Texas, United States